A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
The study, still blinded at an individual level, showed no concerning imbalance in the occurrence of serious adverse events, with more local and influenza-like general reactogenicity, including some grade 3 reactions, reported in the vaccinated group.9 These findings constitute important progress and provide unprecedented opportunity to advance the...
Alternative Titles
Full title
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2173845495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2173845495
Other Identifiers
ISSN
1473-3099
E-ISSN
1474-4457
DOI
10.1016/S1473-3099(19)30003-9
